다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Experimental and molecular pathology, v.86 no.3, 2009년, pp.215 - 223
Singh, R. (Department of Microbiology and Immunology, James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA) , Lillard, J.W.
AI-Helper
Nanotechnology could be defined as the technology that has allowed for the control, manipulation, study, and manufacture of structures and devices in the ''nanometer'' size range. These nano-sized objects, e.g., ''nanoparticles'', take on novel properties and functions that differ markedly from thos...
Mol. Pharm. Ahmed 3 340 2006 10.1021/mp050103u Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation
Chem. Commun. Ashcroft 3004 2006 10.1039/b601717g Fullerene (C60) immunoconjugates: interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody
J. Controlled Release Avgoustakis 79 123 2002 10.1016/S0168-3659(01)00530-2 PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties
Pharmaceut. Sci. Tech. Today Barratt 3 163 2000 10.1016/S1461-5347(00)00255-8 Therapeutic applications of colloidal drug carriers
J. Am. Chem. Soc. Barrera 115 11010 1993 10.1021/ja00076a077 Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine)
Int. J. Pharm. Beletsi 182 187 1999 10.1016/S0378-5173(99)00058-7 Effect of preparative variables on the properties of poly(dl-lactide-co-glycolide)-methoxypoly(ethyleneglycol) copolymers related to their application in controlled drug delivery
Pharmazie Bhadra 57 5 2002 Pegnology: a review of PEG-ylated systems
J. Nanobiotechnology Bisht 5 3 2007 10.1186/1477-3155-5-3 Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy
Adv. Drug Del. Rev. Brigger 54 631 2002 10.1016/S0169-409X(02)00044-3 Nanoparticles in cancer therapy and diagnosis
Pharm. Res. Calvo 14 1431 1997 10.1023/A:1012128907225 Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines
J. Controlled Release Chen 31 49 1994 10.1016/0168-3659(94)90250-X Synthesis of albumin-dextran sulfate microspheres possessing favourable loading and release characteristics for the anticancer drug doxorubicin
Int. J. Peptide Res. Ther. Chen 10 621 2003 10.1007/s10989-004-2433-4 Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide
Crit. Rev. Ther. Drug Carrier Syst. Couvreur 19 99 2002 10.1615/CritRevTherDrugCarrierSyst.v19.i2.10 Nanocapsule technology: a review
Eur. J. Pharm. Biopharm. Couvreur 41 2 1995 Controlled drug delivery with nanoparticles: current possibilities and future trends
Int. J. Pharm. Davda 233 51 2002 10.1016/S0378-5173(01)00923-1 Characterization of nanoparticle uptake by endothelial cells
Pharm. Res. Desai 14 1568 1997 10.1023/A:1012126301290 The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent
Biomaterials Dunne 21 1659 2000 10.1016/S0142-9612(00)00040-5 Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles
CNS Drugs Fisher 16 579 2002 10.2165/00023210-200216090-00001 Potential new methods for antiepileptic drug delivery
J. Pharm. Sci. Fresta 84 895 1995 10.1002/jps.2600840721 Pefloxacine mesilate- and ofloxacin-loaded polyethylcyanoacrylate nanoparticles: characterization of the colloidal drug carrier formulation
Int. J. Pharm. Govender 199 95 2000 10.1016/S0378-5173(00)00375-6 Defining the drug incorporation properties of PLA-PEG nanoparticles
J. Controlled Release Govender 57 171 1999 10.1016/S0168-3659(98)00116-3 PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug
Int. J. Pharm. Grislain 15 335 1983 10.1016/0378-5173(83)90166-7 Pharmacokinetics and distribution of a biodegradable drug-carrier
Circulation Guzman 94 1441 1996 10.1161/01.CIR.94.6.1441 Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty
J. Pharm. Sci. Ge 91 1463 2002 10.1002/jps.10143 Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) amphiphilic triblock copolymer micelles
J. Controlled Release Herrero-Vanrell 102 113 2005 10.1016/j.jconrel.2004.10.001 Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release
Expert Rev. Neurother. Jain 7 363 2007 10.1586/14737175.7.4.363 Use of nanoparticles for drug delivery in glioblastoma multiforme
J. Nanosci. Nanotech. Koo 6 2996 2006 10.1166/jnn.2006.460 Camptothecin in sterically stabilized phospholipid nano-micelles: a novel solvent pH change solubilization method
Kreuter 165 1994 Encyclopaedia of Pharmaceutical Technology Nanoparticles
Kreuter 219 1994 Colloidal Drug Delivery Systems Nanoparticles
Pharma. Res. Kreuter 20 409 2003 10.1023/A:1022604120952 Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles
Neurosurgery Kroll 43 879 1998 10.1097/00006123-199810000-00090 Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers
J. Pharmacol. Exp. Ther. Lamprecht 299 775 2001 Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease
Proc. Natl. Acad. Sci. U. S. A. Lee 103 16649 2006 10.1073/pnas.0607705103 A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas
Linhardt 53 1989 Controlled Release of Drugs Biodegradable polymers for controlled release of drugs
Drug Dev. Ind. Pharm. Lockman 28 1 2002 10.1081/DDC-120001481 Nanoparticle technology for drug delivery across the blood-brain barrier
SMALL Lu 3 1341 2007 10.1002/smll.200700005 Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs
Cancer Cell MacDiarmid 11 431 2007 10.1016/j.ccr.2007.03.012 Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics
Adv. Enzyme Regul. Maeda 41 189 2001 10.1016/S0065-2571(00)00013-3 The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting
Int. J. Pharm. Magenheim 94 115 1993 10.1016/0378-5173(93)90015-8 A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure
J. Nucl. Med. McDevitt 48 1180 2007 10.2967/jnumed.106.039131 Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes
Pharmacol. Rev. Moghimi 53 283 2001 Long-circulating and target-specific nanoparticles: theory to practice
J. Drug Target. Muller 4 161 1996 10.3109/10611869609015973 Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407
NeuroRx Olivier 2 108 2005 10.1602/neurorx.2.1.108 Drug transport to brain with targeted nanoparticles
J. Controlled Release Panyam 92 173 2003 10.1016/S0168-3659(03)00328-6 Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles
Adv. Drug Del. Rev. Panyam 55 329 2003 10.1016/S0169-409X(02)00228-4 Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Int. J. Pharm. Panyam 262 1 2003 10.1016/S0378-5173(03)00295-3 Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d,l-lactide-co-glycolide) nanoparticles
J. Pharm. Sci. Panyam 93 1804 2004 10.1002/jps.20094 Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles
Prostate Peng 67 855 2007 10.1002/pros.20576 Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors
J. Controlled Release Peracchia 46 223 1997 10.1016/S0168-3659(96)01597-0 PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: investigation of their drug encapsulation and release characteristics
Biomaterials Pitt 2 215 1981 10.1016/0142-9612(81)90060-0 Aliphatic polyesters II. The degradation of poly (dl-lactide), poly (epsilon-caprolactone), and their copolymers in vivo
J. Controlled Release Redhead 70 353 2001 10.1016/S0168-3659(00)00367-9 Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation
Bioconjugate Chem. Sahoo 13 1031 2002 10.1021/bc020010k Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity
Pharma. Res. Sutton 24 1029 2007 10.1007/s11095-006-9223-y Functionalized micellar systems for cancer targeted drug delivery
Swarbrick 2002 Encyclopedia of Pharmaceutical Technology
Cancer Res. Tada 67 1138 2007 10.1158/0008-5472.CAN-06-1185 In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice
Expert Opin Drug Deliv. van Vlerken 3 205 2006 10.1517/17425247.3.2.205 Multi-functional polymeric nanoparticles for tumour-targeted drug delivery
J. Controlled Release Vauthier 93 151 2003 10.1016/j.jconrel.2003.08.005 Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles
Expert Opin. Bio. The. Wagner 7 587 2007 10.1517/14712598.7.5.587 Programmed drug delivery: nanosystems for tumor targeting
J. Biomed. Mater. Res. Woodward 19 437 1985 10.1002/jbm.820190408 The intracellular degradation of poly(epsilon-caprolactone)
J. Controlled Release Zauner 71 39 2001 10.1016/S0168-3659(00)00358-8 In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.